VOYA Investment Management
TSHA icon

VOYA Investment Management’s Taysha Gene Therapies TSHA Stock Holding History

VOYA Investment Management’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.9M Sell
425,363
-86,620
-17% -$513K ﹤0.01% 1086
2026
Q1 		$2.29M Buy
511,983
+293,798
+135% +$1.37M ﹤0.01% 1114
2025
Q4 		$1.2M Buy
218,185
+181,685
+498% +$882K ﹤0.01% 1418
2025
Q3 		$119K Sell
36,500
-10,669
-23% -$30.2K ﹤0.01% 2273
2025
Q2 		$109K Sell
47,169
-1,447
-3% -$3.14K ﹤0.01% 2471
2025
Q1 		$67.6K Sell
48,616
-2,600
-5% -$4.35K ﹤0.01% 2508
2024
Q4 		$88.6K Sell
51,216
-3,828
-7% -$7.94K ﹤0.01% 2602
2024
Q3 		$111K Buy
55,044
+1,110
+2% +$2.44K ﹤0.01% 2639
2024
Q2 		$121K Buy
+53,934
New +$157K ﹤0.01% 2620

Other funds holding TSHA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VOYA Investment Management's TSHA Position: Q2 2026 in Review

VOYA Investment Management reduced its Taysha Gene Therapies (TSHA) stake by 17% in Q2 2026, selling an estimated $513K and leaving 425,363 shares worth $2.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1086.

VOYA Investment Management first reported a position in TSHA in Q2 2024 and has held it in 9 quarters since. 209 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • VOYA Investment Management held 425,363 shares of Taysha Gene Therapies worth $2.9M as of Q2 2026.
  • VOYA Investment Management sold 86,620 Taysha Gene Therapies shares in Q2 2026, an estimated $513K.
  • Taysha Gene Therapies made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1086 holding.
  • VOYA Investment Management first reported a position in Taysha Gene Therapies in Q2 2024 and has held it in 9 quarters since.
  • 209 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.